Home
>
National Drug Code (NDC)
>
Vectibix
Vectibix - 55513-955-01 - (panitumumab)
Drug Information of Vectibix
| Product NDC: | 55513-955 |
| Proprietary Name: | Vectibix |
| Non Proprietary Name: | panitumumab |
| Active Ingredient(s): | 200 mg/10mL & nbsp; panitumumab |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Vectibix
| Product NDC: | 55513-955 |
| Labeler Name: | Amgen Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125147 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20061010 |
Package Information of Vectibix
| Package NDC: | 55513-955-01 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (55513-955-01) > 10 mL in 1 VIAL, SINGLE-USE |
NDC Information of Vectibix
| NDC Code | 55513-955-01 |
| Proprietary Name | Vectibix |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (55513-955-01) > 10 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 55513-955 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | panitumumab |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20061010 |
| Marketing Category Name | BLA |
| Labeler Name | Amgen Inc |
| Substance Name | PANITUMUMAB |
| Strength Number | 200 |
| Strength Unit | mg/10mL |
| Pharmaceutical Classes | Epidermal Growth Factor Receptor Antagonist [EPC] |
